Ignite Creation Date:
2025-12-24 @ 3:50 PM
Ignite Modification Date:
2025-12-25 @ 4:25 PM
Study NCT ID:
NCT05821192
Status:
UNKNOWN
Last Update Posted:
2023-04-20
First Post:
2023-03-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Chemotherapy Plus PD-1 Monoclonal Antibody in the Treatment of Refractory or Relapsed Peripheral T-cell Lymphoma.
Sponsor:
Ou Bai, MD/PHD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03-23
Start Date Type:
ACTUAL
Primary Completion Date:
2023-04-18
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-03-23
First Submit QC Date:
None
Study First Post Date:
2023-04-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-07
Last Update Post Date:
2023-04-20
Last Update Post Date Type:
ACTUAL